DeutschNewstral
Article
bizjournals.com on 2015-05-27 20:38
$737M deal between Editas and Juno a 'compelling marriage' of two approaches
Related news
Eleventh Circuit Reverses Order Compelling Arbitration Between Non-Signatoriesjdsupra.com- MEditas stock down 21% after announcing CEO departuremarketwatch.com
Juno approaches halfway mark of its science missionnewatlas.com
Beigene, Editas Medicine shares rise in market debutswkrg.com- Cambridge's Editas asks FDA to start gene editing trialbizjournals.com
- Marvin Claims Between Unmarried Partners Will Abound in Post-Marriage California – A Conversation with Jeffrey Makoffjdsupra.com
- Editas Medicine taps former Biogen leader as CEObizjournals.com
Intellia, Editas: How Are Gene Editing Stocks Faring?Forbes- TMARRIAGE BETWEEN SPIRIT, MATTERtimes.co.sz
- Juno stock drops on report of lackluster immunotherapy results on solid tumorsbizjournals.com
Seattle’s Juno Therapeutics ready for another round in war on cancer - Mon, 25 Sep 2017 PSTThe Spokesman-Review
JUNOmcall.com
'Compelling case for creating the CAM'cambridgeindependent.co.uk- CRISPR, Editas, Intellia: Gene Editing Stocks To Play The Next Revolution In MedicineForbes
- Can Editas Medicine Stock Bounce Back After A 13% Drop In 5 Days ?Forbes
Zelensky: Trump Would Be a 'Loser' President if He Forces a Peace Deal Between Russia and Ukrainebreitbart.com
Italy Approaches Its Own Choice Between Liberalism and PopulismThe New Yorker- BUnholy marriage between metal and discobristolobserver.com
Deficit complicates marriage between Trump, GOP lawmakersdothaneagle.com